thus , autoantibodies reactive with the insulin molecule ( 1 ) appear to constitute an additional serologic marker of ongoing autoimmunity and development of iddm , and ( 2 ) may reflect heterogeneity in the pathogenesis of iddm .
C0021641
insulin
C0011854
iddm